Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ; KEYNOTE-040 investigators. Cohen EEW, et al. Among authors: dinis j. Lancet. 2019 Jan 12;393(10167):156-167. doi: 10.1016/S0140-6736(18)31999-8. Epub 2018 Nov 30. Lancet. 2019. PMID: 30509740 Clinical Trial.
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck.
Saloura V, Cohen EE, Licitra L, Billan S, Dinis J, Lisby S, Gauler TC. Saloura V, et al. Among authors: dinis j. Cancer Chemother Pharmacol. 2014 Jun;73(6):1227-39. doi: 10.1007/s00280-014-2459-z. Epub 2014 Apr 9. Cancer Chemother Pharmacol. 2014. PMID: 24714973 Clinical Trial.
Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.
Burtness B, Haddad R, Dinis J, Trigo J, Yokota T, de Souza Viana L, Romanov I, Vermorken J, Bourhis J, Tahara M, Martins Segalla JG, Psyrri A, Vasilevskaya I, Nangia CS, Chaves-Conde M, Kiyota N, Homma A, Holeckova P, Del Campo JM, Asarawala N, Nicolau UR, Rauch D, Even C, Wang B, Gibson N, Ehrnrooth E, Harrington K, Cohen EEW; LUX-Head & Neck 2 investigators. Burtness B, et al. Among authors: dinis j. JAMA Oncol. 2019 Aug 1;5(8):1170-1180. doi: 10.1001/jamaoncol.2019.1146. JAMA Oncol. 2019. PMID: 31194247 Free PMC article.
Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.
Harrington KJ, Soulières D, Le Tourneau C, Dinis J, Licitra LF, Ahn MJ, Soria A, Machiels JH, Mach N, Mehra R, Burtness B, Ellison MC, Cheng JD, Chirovsky DR, Swaby RF, Cohen EEW. Harrington KJ, et al. Among authors: dinis j. J Natl Cancer Inst. 2021 Feb 1;113(2):171-181. doi: 10.1093/jnci/djaa063. J Natl Cancer Inst. 2021. PMID: 32407532 Free PMC article.
Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence.
Harrington KJ, Cohen EEW, Soulières D, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Swaby RF, Lin J, Ge J, Lerman N, Tourneau CL. Harrington KJ, et al. Among authors: dinis j. Oral Oncol. 2023 Dec;147:106587. doi: 10.1016/j.oraloncology.2023.106587. Epub 2023 Nov 3. Oral Oncol. 2023. PMID: 37925894 Free article. Clinical Trial.
A 10-year review of primary major salivary gland cancers.
Cruz A, Magalhães H, Pereira FF, Dinis J, Vieira C. Cruz A, et al. Among authors: dinis j. Ecancermedicalscience. 2020 Jun 12;14:1055. doi: 10.3332/ecancer.2020.1055. eCollection 2020. Ecancermedicalscience. 2020. PMID: 32582370 Free PMC article.
Management of Locally Advanced Esthesioneuroblastoma in a Pregnant Woman.
Guerreiro IM, Vieira C, Soares A, Braga A, Jácome M, Dinis J. Guerreiro IM, et al. Among authors: dinis j. Case Rep Oncol Med. 2019 Aug 19;2019:3789317. doi: 10.1155/2019/3789317. eCollection 2019. Case Rep Oncol Med. 2019. PMID: 31531255 Free PMC article.
Hereditary gastrointestinal stromal tumors sharing the KIT Exon 17 germline mutation p.Asp820Tyr develop through different cytogenetic progression pathways.
Veiga I, Silva M, Vieira J, Pinto C, Pinheiro M, Torres L, Soares M, Santos L, Duarte H, Bastos AL, Coutinho C, Dinis J, Lopes C, Teixeira MR. Veiga I, et al. Among authors: dinis j. Genes Chromosomes Cancer. 2010 Feb;49(2):91-8. doi: 10.1002/gcc.20720. Genes Chromosomes Cancer. 2010. PMID: 19847891
103 results